AnesthesiaNCT05512728
Efficacy of Virtual Reality Distraction Technique for Anxiety and Pain Control in Orthopedic Forearm Surgeries Performed Under Supraclavicular Brachial Plexus Block
A study testing VR and Midazolam in people with Anesthesia, run by Cairo University at 2 sites in Egypt.
Trial summary
Invistigators hypothesized that using of VR distraction technique during performing peripheral regional anesthesia (supraclavicular block) would lead to better perioperative analgesia and less anxiety. Read more about this study
- Who is it for?
- Ages 18 to 60 years
- Conditions the study is for
- Anesthesia
- What is being tested?
- VR and Midazolam
- Type of treatment
- Medical device
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 30 participants
- Where
- 2 sitesEgypt
- Study dates
- 20 Dec 2020to 20 Dec 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 60 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- ASA physical status I-II. patients scheduled for elective forearm orthopedic surgeries under ultrasound guided supraclavicular approach for brachial plexus block with good mental function.
Who cannot join
- Patient's refusal.
- Known allergy to local anesthetics.
- Bleeding disorders, Use of any anti-coagulants.
- Inability to provide informed consent.
- Patient with psychiatric disorders.
- Sensory impairment (blindness, deafness).
Show all 9Show fewer
- Any technical problem preventing proper fitting of the glasses to the patient face
- patients with cognitive impairment, epilepsy or with claustrophobia
- patients with suspected eye infection
Trial locations and contacts
2 sites in 1 country.
About this study
Invistigators hypothesized that using of VR distraction technique during performing peripheral regional anesthesia (supraclavicular block) would lead to better perioperative analgesia and less anxiety.
Read the detailed description
Methodology I. Study design This is a controlled randomized prospective study. II. Study setting and location The study will be conducted at Cairo University Hospital - orthopedic surgery unit.
III. Study population Participants will be adult patients (above 18 years), ASA I-II, scheduled for elective forearm orthopedic surgeries under ultrasound guided supraclavicular approach for brachial plexus block.
IV. Study Procedures
- Randomization Patients will be randomly allocated by a computer-generated table into one of the study groups; the randomization sequence will be concealed in sealed envelopes. Patients and data collector will be blind to group assignment.
- Study Protocol Following approval from Ethics and Research Committee of Anesthesia Department, Faculty of Medicine, Cairo University, All patients will be subjected to systematic preoperative assessment including history taking, physical examination, and review of the results of routine investigations.
Upon arrival to the preparation room: A 20 gauge IV cannula is inserted into a peripheral vein then patients will be transferred to the operating room where basic monitoring Electrocardiography (ECG), Non-invasive Blood Pressure (NIBP) and pulse oximetry are attached. Baseline heart rate, blood pressure, oxygen saturation and respiratory rate will be recorded.
All patients will receive ultrasound guided supraclavicular block. The skin is disinfected and the transducer is positioned in the transverse plane immediately proximal to the clavicle, the transducer is tilted caudally, as if to image the chest contents, to obtain a cross-sectional view of the subclavian artery the brachial plexus is seen as a collection of hypo echoic oval structures posterior and superficial to the artery... Using a 25- to 27-gauge needle, 1-2 mL of local anesthetic is injected into the skin 1 cm lateral to the transducer .The distribution of local anesthetic via small-volume injections is observed as the needle advances through tissue layers (hydro-localization); small-volume injections are used to avoid inadvertent needle insertion into the brachial plexus. The block needle is then inserted in plane toward the brachial plexus, in a lateral-to-medial direction... Insertion of the needle into the sheath is often associated with a palpable "pop." After careful aspiration, 1-2 mL of local anesthetic is injected to confirm proper needle placement. When the injection displaces the brachial plexus away from the needle, an additional advancement of the needle 1-2 mm closer to the plexus may be required to accomplish adequate local anesthetic spread. When the injection of local anesthetic does not appear to result in a spread around the brachial plexus, needle repositioning may be necessary. Typically, 20-25 mL of local anesthetic is required for adequate block.
After local anesthetic injection through the block needle, measurements of brachial plexus blockade will be performed every 5 minutes until 30 minutes. Sensory blockade of the musculocutaneous, median, radial, and ulnar nerves was graded according to a 3-point scale using a cold test: 0 = no block, 1 = analgesia (patient can feel touch, not cold), 2 = anesthesia (patient cannot feel touch). Sensory blockade of the musculocutaneous, median, radial, and ulnar nerves will be assessed on the lateral aspect of the forearm, the volar aspect of the thumb, the lateral aspect of the dorsum of the hand, and the volar aspect of the fifth finger, respectively. Motor blockade will be also graded on a 3-point scale: 0 = no block, 1 = paresis, 2 = paralysis. Motor blockade of the musculocutaneous, radial, median, and ulnar nerves was evaluated by elbow flexion, thumb abduction, thumb opposition, and thumb adduction, respectively. Overall, the maximal composite score was 16 points. We will consider the patient ready for surgery when a minimal composite score of 14 points is achieved, provided the sensory block score is equal or superior to 7 of 8 points. (12) If, after 30 minutes, the composite score was <14 points, the patient will be excluded from the study and further management will be according to discretion of the attending anesthetist.
Patients in control group will not receive any additional management Patient in the VR group, before wearing the device, they will have the procedure explained to them, and reassured that they can terminate the VR session any time during the procedure. The VR set will be applied before performing the supraclavicular block and will be removed at the end of the procedure before leaving the operating room.
IVR simulation used:
The IVR environment was provided by Shinecon VR (Shinecon, china). Shinecon VR features, have a large field of view and high-quality display; with aspheric lens , lens diameter 40MM, view angle 108 , sharpness 99%, visibility 100%, color .38MM and pupillary distance adjustment 65 MM.
The shinecon VR setup was powered by a HUAWEI Y7 prime phone running the freely available IVR software.
Shinecon VR provides videos for nature, forest, wind, desert and animals. That included noise-cancelling headphones playing background sound from the IVR simulation.
•
Intraoperative sedation:
- (titration of 0.05 mg/kg per dose) according to Modified Wilson sedation scale Score to achieve grade 1 (Oriented, eyes may be closed but can respond to 'Can you tell me your name?' 'Can you tell me where you are right now?'
- titration of analgesia (fentanyl 1 mcg/kg per dose) according to numeric pain score to reach Zero pain.
- titration will be administered to all patients according to the attending anesthetist dissertation
Ultrasound-guided supraclavicular brachial plexus block simulating a single injection between the subclavian artery (SA) and the first rib Measured Parameter Demographic data of the patient
- Hemodynamics (heart rate, systolic and diastolic arterial blood pressure) will be recorded at baseline (upon patient admission to OR), 1 min after block then every 5 minutes till skin incision, 1 minute after skin incision and every 5 minutes till skin closure
- Total dos of midazolam needed for patient to relieve anxiety.
- The total dose of fentanyl
- The VR group, time required to set-up the virtual reality device, session lengths, early discontinuation, adverse events, such as: headache, nausea, or vomiting; and proportion of patients wishing to use the technology again
- The sedation level will be monitored using Modified Wilson sedation scale Score Description
- Oriented, eyes may be closed but can respond to 'Can you tell me your name?' 'Can you tell me where you are right now?'
- Drowsy; eyes may be closed, arousable only to command: '(name), please open your eyes'.
- Arousable to mild physical stimulation (earlobe tug)
- Unarousable to mild physical stimulation
- The pain level will be monitored using numeric pain scale
- Conditions
- Anesthesia
- Being tested
- VR, Midazolam
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
VRDevice
The IVR environment was provided by Shinecon VR (Shinecon, china). Shinecon VR features, have a large field of view and high-quality display; with aspheric lens , lens diameter 40MM, view angle 108 , sharpness 99%, visibility 100%, color .38MM and pupillary distance adjustment 65 MM.
The shinecon VR setup was powered by a HUAWEI Y7 prime phone running the freely available IVR software.
Shinecon VR provides videos for nature, forest, wind, desert and animals. That included noise-cancelling headphones playing background sound from the IVR simulation.
MidazolamDrug
- (titration of 0.05 mg/kg per dose) according to Modified Wilson sedation scale Score to achieve grade 1 (Oriented, eyes may be closed but can respond to 'Can you tell me your name?' 'Can you tell me where you are right now?'
| Study group | Role | What they receive |
|---|---|---|
| midazolam group | Placebo comparator | Not described Receives: Drug: Midazolam |
| VR group | Active comparator | Not described Receives: Device: VR |
What is being measured
The primary outcome is the main question the study is designed to answer.
● To estimate amount of IV sedation needed for the patient
Measured: (time from block needle entry till the end of the procedure)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Aug 2022
- Study start20 Dec 2020
- Primary completion20 Dec 2022 (estimated)
- Study completion20 Dec 2022 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for AnesthesiaStudies of the same condition, open and under way.
- More trials run by Cairo UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Sequential
- Model description
- Categorical variables will be assessed using the chi-square or Fischer's exact test where appropriate. Normally distributed data will be presented as the mean (SD). Midazolam consumption and hemodynamic variables with a normal distribution will be analyzed using two-way analyses of variance with repeated measures and Dennett's post hoc test as appropriate. Data that are not normally distributed (by the Kolmogorov-Smirnov test) are presented as the median (range) and will be analyzed with the Kruskal-Wallis test as appropriate. The software SPSS v15.0 for Windows (SPSS, Inc, Chicago, IL, United States) will be used for statistical analysis
- Masking
- Single blind
- Who is masked
- Care provider
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Cairo University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Haitham Hassan Eltrabily, Cairo University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05512728
- Sponsor's protocol ID
- MS-389-2020
- Status last verified
- Aug 2022
- First submitted
- 20 Aug 2022
- Last updated
- 31 Aug 2022
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 31 Aug 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Efficacy of Virtual Reality Distraction Technique for Anxiety and Pain Control in Orthopedic Forearm Surgeries Performed Under Supraclavicular Brachial Plexus Block
- ClinicalTrials.gov ID
- NCT05512728
- Acronym / sponsor ID
- MS-389-2020
- Conditions
- Anesthesia
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- Cairo UniversityUniversity, hospital or other
- Study start
- 20 Dec 2020 (actual)
- Primary completion
- 20 Dec 2022 (estimated)
- Study completion
- 20 Dec 2022 (estimated)
- First posted
- 23 Aug 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Invistigators hypothesized that using of VR distraction technique during performing peripheral regional anesthesia (supraclavicular block) would lead to better perioperative analgesia and less anxiety.
Detailed description
Methodology I. Study design This is a controlled randomized prospective study. II. Study setting and location The study will be conducted at Cairo University Hospital - orthopedic surgery unit.
III. Study population Participants will be adult patients (above 18 years), ASA I-II, scheduled for elective forearm orthopedic surgeries under ultrasound guided supraclavicular approach for brachial plexus block.
IV. Study Procedures
- Randomization Patients will be randomly allocated by a computer-generated table into one of the study groups; the randomization sequence will be concealed in sealed envelopes. Patients and data collector will be blind to group assignment.
- Study Protocol Following approval from Ethics and Research Committee of Anesthesia Department, Faculty of Medicine, Cairo University, All patients will be subjected to systematic preoperative assessment including history taking, physical examination, and review of the results of routine investigations.
Upon arrival to the preparation room: A 20 gauge IV cannula is inserted into a peripheral vein then patients will be transferred to the operating room where basic monitoring Electrocardiography (ECG), Non-invasive Blood Pressure (NIBP) and pulse oximetry are attached. Baseline heart rate, blood pressure, oxygen saturation and respiratory rate will be recorded.
All patients will receive ultrasound guided supraclavicular block. The skin is disinfected and the transducer is positioned in the transverse plane immediately proximal to the clavicle, the transducer is tilted caudally, as if to image the chest contents, to obtain a cross-sectional view of the subclavian artery the brachial plexus is seen as a collection of hypo echoic oval structures posterior and superficial to the artery... Using a 25- to 27-gauge needle, 1-2 mL of local anesthetic is injected into the skin 1 cm lateral to the transducer .The distribution of local anesthetic via small-volume injections is observed as the needle advances through tissue layers (hydro-localization); small-volume injections are used to avoid inadvertent needle insertion into the brachial plexus. The block needle is then inserted in plane toward the brachial plexus, in a lateral-to-medial direction... Insertion of the needle into the sheath is often associated with a palpable "pop." After careful aspiration, 1-2 mL of local anesthetic is injected to confirm proper needle placement. When the injection displaces the brachial plexus away from the needle, an additional advancement of the needle 1-2 mm closer to the plexus may be required to accomplish adequate local anesthetic spread. When the injection of local anesthetic does not appear to result in a spread around the brachial plexus, needle repositioning may be necessary. Typically, 20-25 mL of local anesthetic is required for adequate block.
After local anesthetic injection through the block needle, measurements of brachial plexus blockade will be performed every 5 minutes until 30 minutes. Sensory blockade of the musculocutaneous, median, radial, and ulnar nerves was graded according to a 3-point scale using a cold test: 0 = no block, 1 = analgesia (patient can feel touch, not cold), 2 = anesthesia (patient cannot feel touch). Sensory blockade of the musculocutaneous, median, radial, and ulnar nerves will be assessed on the lateral aspect of the forearm, the volar aspect of the thumb, the lateral aspect of the dorsum of the hand, and the volar aspect of the fifth finger, respectively. Motor blockade will be also graded on a 3-point scale: 0 = no block, 1 = paresis, 2 = paralysis. Motor blockade of the musculocutaneous, radial, median, and ulnar nerves was evaluated by elbow flexion, thumb abduction, thumb opposition, and thumb adduction, respectively. Overall, the maximal composite score was 16 points. We will consider the patient ready for surgery when a minimal composite score of 14 points is achieved, provided the sensory block score is equal or superior to 7 of 8 points. (12) If, after 30 minutes, the composite score was <14 points, the patient will be excluded from the study and further management will be according to discretion of the attending anesthetist.
Patients in control group will not receive any additional management Patient in the VR group, before wearing the device, they will have the procedure explained to them, and reassured that they can terminate the VR session any time during the procedure. The VR set will be applied before performing the supraclavicular block and will be removed at the end of the procedure before leaving the operating room.
IVR simulation used:
The IVR environment was provided by Shinecon VR (Shinecon, china). Shinecon VR features, have a large field of view and high-quality display; with aspheric lens , lens diameter 40MM, view angle 108 , sharpness 99%, visibility 100%, color .38MM and pupillary distance adjustment 65 MM.
The shinecon VR setup was powered by a HUAWEI Y7 prime phone running the freely available IVR software.
Shinecon VR provides videos for nature, forest, wind, desert and animals. That included noise-cancelling headphones playing background sound from the IVR simulation.
•
Intraoperative sedation:
- (titration of 0.05 mg/kg per dose) according to Modified Wilson sedation scale Score to achieve grade 1 (Oriented, eyes may be closed but can respond to 'Can you tell me your name?' 'Can you tell me where you are right now?'
- titration of analgesia (fentanyl 1 mcg/kg per dose) according to numeric pain score to reach Zero pain.
- titration will be administered to all patients according to the attending anesthetist dissertation
Ultrasound-guided supraclavicular brachial plexus block simulating a single injection between the subclavian artery (SA) and the first rib Measured Parameter Demographic data of the patient
- Hemodynamics (heart rate, systolic and diastolic arterial blood pressure) will be recorded at baseline (upon patient admission to OR), 1 min after block then every 5 minutes till skin incision, 1 minute after skin incision and every 5 minutes till skin closure
- Total dos of midazolam needed for patient to relieve anxiety.
- The total dose of fentanyl
- The VR group, time required to set-up the virtual reality device, session lengths, early discontinuation, adverse events, such as: headache, nausea, or vomiting; and proportion of patients wishing to use the technology again
- The sedation level will be monitored using Modified Wilson sedation scale Score Description
- Oriented, eyes may be closed but can respond to 'Can you tell me your name?' 'Can you tell me where you are right now?'
- Drowsy; eyes may be closed, arousable only to command: '(name), please open your eyes'.
- Arousable to mild physical stimulation (earlobe tug)
- Unarousable to mild physical stimulation
- The pain level will be monitored using numeric pain scale
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Sequential
- Masking
- Single blind (care provider)
- Number of arms
- 2
- Model description
- Categorical variables will be assessed using the chi-square or Fischer's exact test where appropriate. Normally distributed data will be presented as the mean (SD). Midazolam consumption and hemodynamic variables with a normal distribution will be analyzed using two-way analyses of variance with repeated measures and Dennett's post hoc test as appropriate. Data that are not normally distributed (by the Kolmogorov-Smirnov test) are presented as the median (range) and will be analyzed with the Kruskal-Wallis test as appropriate. The software SPSS v15.0 for Windows (SPSS, Inc, Chicago, IL, United States) will be used for statistical analysis
| Arm | Type | Receives |
|---|---|---|
| midazolam group | Placebo comparator | Drug: Midazolam |
| VR group | Active comparator | Device: VR |
Who may qualify
- Ages
- 18 to 60 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (1 listed)
- ASA physical status I-II. patients scheduled for elective forearm orthopedic surgeries under ultrasound guided supraclavicular approach for brachial plexus block with good mental function.
Key exclusion criteria (9 listed)
- Patient's refusal.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| VRThe IVR environment was provided by Shinecon VR (Shinecon, china). Shinecon VR features, have a large field of view and high-quality display; with aspheric lens , lens diameter 40MM, view angle 108 , sharpness 99%, visibility 100%, color .38MM and pupillary distance adjustment 65 MM. The shinecon VR setup was powered by a HUAWEI Y7 prime phone running the freely available IVR software. Shinecon VR provides videos for nature, forest, wind, desert and animals. That included noise-cancelling headphones playing background sound from the IVR simulation. | Device | VR group |
| Midazolam• (titration of 0.05 mg/kg per dose) according to Modified Wilson sedation scale Score to achieve grade 1 (Oriented, eyes may be closed but can respond to 'Can you tell me your name?' 'Can you tell me where you are right now?' | Drug | midazolam group |
Primary outcome
● To estimate amount of IV sedation needed for the patient
Time frame: (time from block needle entry till the end of the procedure)
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 31 Aug 2022.
- Individual participant dataSharing planned: Undecided
Related trials for Anesthesia
Not yet recruitingObservational study
"Comparison of Oxygen Reserve Index (ORI), End-Tidal Oxygen, and Time-Based Preoxygenation Targets With Arterial Blood Gas During Preoxygenation
Preoxygenation Adequacy Assessed by Oxygen Reserve Index, End-tidal Oxygen and Arterial Blood Gas
RecruitingObservational study
Comparison of Hemodynamic Responses During Anesthesia Induction Using Eleveld and Schnider
Spinal (Fusion) Surgery, Total Intravenous Anesthesia
Not yet recruiting
A Randomized Controlled SaCo-VLM Trial
General Anaesthesia Using Supraglotic Airway
Not yet recruiting
Bispectral Index-Guided Propofol Sedation During Endoscopic Retrograde Cholangiopancreatography
Deep Sedation, Endoscopic Retrograde Cholangiopancreatography
RecruitingPhase 4
Comparison of Hemodynamics and Respiratory Function Between Ciprofol and Propofol in Elderly Patients Undergoing Non-intubated General Anesthesia
Comparison of Hemodynamics and Respiratory Function Between Ciprofol and Propofol in Elderly Patients Undergoing Non-intubated General Anesthesia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing VR and Midazolam in people with Anesthesia, run by Cairo University at 2 sites in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 31 Aug 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
● To estimate amount of IV sedation needed for the patient (time frame: (time from block needle entry till the end of the procedure)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Aug 2022.